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Megalencephalic leukoencephalopathy with subcortical cysts (MLC; MIM#604004) is a rare congenital disorder of the cere-
bral white matter. Most MLC patients have MLC1 mutations which are inherited in an autosomal recessive manner. Since
there is no established biomarker for MLC, genetic testing is necessary for a final diagnosis. We identified compound het-
erozygous mutations in two different Japanese patients having MLC. Both patients showed a common mutation of c.278C>T
(p.Ser93Leu) in a heterozygous status. In addition, two different mutations (c.337_353delinsG and c.423+1G>A) were identi-
fied in the homologous alleles of the patients, respectively. Although these two variants were first identified in the Japanese
population, they have since been reported in other Asian countries and might be founder mutations of the gene in Asian
population.
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Introduction
Megalencephalic leukoencephalopathy with subcortical
cysts (MLC; MIM#604004) is a congenital disorder of
the cerebral white matter.
１
Patients with MLC typically
show megalencepahly since the neonatal period. Thus,
patients with MLC are often referred to the hospital by a
health checkup system for neonates and are radiologi-
cally examined. If the patients exhibit cystic-like findings
in the subcortical white matter, presence of MLC would
be strongly suggested. White matter involvement and
clinical severity often display step-wise progression.
Most patients with MLC have MLC1 mutations which
are inherited in an autosomal recessive manner.
２
Since
there is no biomarker for MLC, genetic testing is neces-
sary for a final diagnosis. Previously, many genetic muta-
tions have been reported for MLC.
３
Here, we report on
two additional patients with MLC.
Case Reports
Patient 1 is a 3-year-old Japanese boy, who was born at
39 weeks of gestation, with a birth occipitofrontal cir-
cumference (OFC) of 36.0 cm (> 97th centile), indicating
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Figure　1　Results of MRI examination. Patient 1 shows cystic-like findings in the subcortical white 
matter (A; white arrows) and diffuse white matter involvement (B). Patient 2 shows diffuse T1-low (C) 
and T2-hypointensities (D) in the white matter. 
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macrocephaly. The patient is the only child of his healthy
parents who were non-consanguineous. His family his-
tory is no-remarkable. His OFC was measured to be 48.0
cm (> 97th centile) during a health checkup at 5 months,
and macrocephaly became remarkable. Then, he was re-
ferred to the hospital, and brain magnetic resonance im-
aging (MRI) displayed a high T2 intensity in the white
matter, in association with suspected cystic findings in
the subcortical region, suggesting the presence of MLC.
At present, he shows mildly delayed motor development,
probably due to macrocephaly with an OFC of 57.3 cm
(> 97th centile). Brain MRI clearly demonstrated typical
MLC findings (Figure 1A and B).
Patient 2 is a 14-month-old Japanese girl, who was
born at 36 weeks of gestation, with a birth weight of
2,435 g. The patient is the only child of her healthy par-
ents who were non-consanguineous. There is no-
remarkable family history. During early infancy, the pa-
tient showed normal development; however, she demon-
strated mildly delayed gross motor development. At 10
months, she could not sit upright and macrocephaly was
also noted. Then, she was referred to the hospital and her
brain MRI displayed a diffuse white matter abnormality
(Figure 1C and D).
Molecular Diagnosis
Since MLC was suspected in both the patients, genetic
diagnosis was performed. This study was approved by
the institutional ethics committee (#338C) and performed
in accordance with the Declaration of Helsinki. Written
informed consent was obtained from the families, and pe-
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Figure　2　Electropherograms of Sanger sequencing. The c.278C>T is commonly observed (A). Both 
c.337_353delinsG (B) and c.423+1G>A (C) are shown as heterozygous.  
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ripheral blood samples were obtained from the patients
and their parents.
First, the common mutation, NM_139202(MLC1_v
001):c.278C>T (p.Ser93Leu), in exon 4 was confirmed
by PCR Sanger sequencing according to a previous re-
port.
３
Since both the patients displayed the mutation in a
heterozygous status (Figure 2A), other exons were sub-
sequently analyzed. NM_139202(MLC1_v001):c.337_
353 delinsG ( p. Ile 113 Glyfs * 4 ) in exon 5 and NM _
139202(MLC1_v001):c.423+1G>A in intron 6 were
identified in patient 1 and patient 2, respectively (Fig-
ure 2B and C).
In patient 1, the p.Ser93Leu and the p.Ile113Glyfs*4
were inherited from the mother and the father, respec-
tively. In patient 2, the p.Ser93Leu and the c.423+1G>A
were inherited from the father and the mother, respec-
tively. Therefore, both the patients showed MLC1 muta-
tions as a compound heterozygous pattern.
Discussion
The p.Ser93Leu mutation was first identified in 2003.
４
Subsequently, this mutation has been recognized as a
common mutation among Japanese patients with MLC.
５
Indeed, in our laboratory, all previous patients with MLC
displayed p.Ser93Leu in at least one allele.
３
Thus, we
firstly check the existence of p.Ser93Leu in patients with
suspected MLC.
In this study, we initially identified p.Ser93Leu in two
patients. Subsequently, we analyzed all exons with confi-
dence. As expected, two different mutations were identi-
fied in both the patients in combination with p.Ser93Leu.
Thus, this supported the fact that our strategy was reason-
able.
The mutation, c.337_353delinsG (p.Ile113Glyfs*4),
identified in patient 1 and his father, is related to a
frameshift alteration. Thus, loss-of-function was sus-
pected as a consequence. This mutation has only been re-
ported in Korea.
６
The mutation, c.423+1G>A, identified
in patient 2 and her mother, was located on the splice do-
nor site and hence is considered to cause a splicing ab-
normality. This splicing mutation has only been reported
in Iran.
７
Although these two mutations are the first to be
found in Japanese population, it is extremely rare that the
same mutations occur independently in the same popula-
tion. Therefore, these mutations are considered to be
founder mutations in Asian population.
Generally, clinical features of the patients with MLC
are variable and there is no clear genotype-phenotype
correlation in MLC. Thus, it is hard to predict future




Anyway, since both the parents in the two families
were carriers of MLC1 mutations, these two couples have
recurrent risk in future pregnancies. Therefore, genetic
information identified in this study would be beneficial
for genetic counseling and future prenatal diagnosis.
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